UnitedHealth Group Incorporated (UNH)
Nesbitt: Economy Remains Strong, Bull Case for UNH, LEVI & VLO
Don Nesbitt sees the economy staying strong even as cracks in the labor force appear to widen. However, he doesn't see the stock market moving significantly higher given current valuations, nor does Don expect interest rates to add momentum at current levels.
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $353.72, denoting a +1.56% move from the preceding trading day.
Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Wall Street Analysts Think UnitedHealth (UNH) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
UnitedHealth to exit Medicare Advantage plans in 16 US counties
UnitedHealth said it will stop offering Medicare Advantage plans in 16 U.S. counties in 2026, impacting 180,000 members, as the company balances higher costs with reimbursement pressure in the insurance program.
Buy or Fear UNH Stock At $345?
UnitedHealth Group stock (NYSE: UNH) is up 16% this month, driven by several positive factors. Last month, Warren Buffett disclosed a $1.6 billion stake in the company.
UnitedHealth: I Can Confidently Say The Worst Is Arguably Over (Upgrade)
UnitedHealth Group investors have continued to outperform the S&P 500 and the healthcare sector since its plunge in July 2025. UNH's reaffirmed 2025 guidance and constructive Medicare Advantage star ratings support conviction in its earnings recovery and long-term outlook. Based on the forecasted 2027 earnings outlook, the market may not have fully upgraded its optimism on the stock, paving the way for investors to consider doubling down.
UnitedHealth Group: No Guarantees Of Upside, But The Bottom Appears In
Shares are consolidating after a strong rebound, with the bottom likely in and a 2026-focused outlook. Recent management changes and reaffirmed guidance signal stabilization, despite ongoing margin pressures from elevated medical costs and integration of Amedisys. UNH's strong Medicare Star Ratings position it for bonus revenues in 2027, while notable institutional investors have initiated or increased positions.
Billionaires From Warren Buffett to David Tepper and Michael Platt Are Piling Into This Dirt-Cheap Stock. Is It a Once-in-a-Decade Buying Opportunity?
Investors love to have a look at what stocks billionaires are buying and selling. And the reason is simple.
UnitedHealth (UNH) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
UnitedHealth sought to meet Trump, WSJ reports
UnitedHealth has sought meetings with U.S. President Donald Trump, although it has not secured a meeting yet, the Wall Street Journal reported on Sunday.
Why I'm Buying More UnitedHealth Than Centene
UnitedHealth Group stands out as the preferred pick over Centene due to scale, diversification, and higher profitability. UNH's integrated model and Optum platform provide more growth avenues and resilience compared to CNC's focus on government-sponsored programs. While CNC trades at a discount, UNH's stronger margins, return on equity, and diversified revenue streams justify its premium valuation.
